摘要
目的 探讨复方苦参注射液联合拉米夫定治疗慢性乙型肝炎的临床疗效.方法 选取2012年8月至2013年9月于驻马店市中心医院治疗的126例慢性乙型肝炎患者,将其随机分为对照组和观察组,每组63例,两组均予以常规治疗,对照组加用拉米夫定治疗,观察组加用复方苦参注射液联合拉米夫定治疗,分析对比两组患者的临床治疗效果.结果 对照组HBV-DNA转阴37例,占58.7％,观察组52例,占82.5％,观察组明显高于对照组（P＜0.05）.结论 采用复方苦参注射液联合拉米夫定治疗慢性乙型肝炎疗效显著,可有效提高患者HVV-DNA转阴率,值得广泛应用推广.
Objective To investigate the clinical efficacy of compound matrine injection combined with lamivudine on chronic hepatitis B.Methods One hundred and twenty-six cases of chronic hepatitis B patients were selected from 2012 August to 2013 September in our hospital.They were randomly divided into control group and observation group,each group had 63 cases.The two groups were both given regular treatment.And the control group was treated with lamivudine,the observation group was treated with Compound Kushen injection combined with lamivudine.The clinical therapeutic effects of the two groups were compared.Results In the control group,37 patients with negative HBV-DNA,accounting for 58.7％.In the observation group,52 patients with HBV-DNA negative,accounting for 82.5％.The HBV-DNA negative rate in observation group was significantly higher than that in the control group （P ＜ 0.05）.Conclusions Compound matrine injection combined with lamivudine in the treatment of chronic hepatitis B were significantly.It can effectively improve the patients with HVV-DNA negative rate,and is worthy of wide application.
出处
《中国实用医刊》
2014年第23期74-75,共2页
Chinese Journal of Practical Medicine
